X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20370) 20370
Magazine Article (95) 95
Newsletter (39) 39
Book / eBook (6) 6
Web Resource (6) 6
Dissertation (5) 5
Publication (5) 5
Book Chapter (4) 4
Book Review (4) 4
Conference Proceeding (4) 4
Government Document (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17120) 17120
piperazines - therapeutic use (14558) 14558
male (10358) 10358
female (7633) 7633
middle aged (6074) 6074
imatinib mesylate (5892) 5892
adult (5691) 5691
piperazines - pharmacology (5180) 5180
pyrimidines - therapeutic use (5110) 5110
animals (4913) 4913
benzamides (4901) 4901
aged (3968) 3968
antineoplastic agents - therapeutic use (3840) 3840
treatment outcome (3428) 3428
piperazines - adverse effects (3403) 3403
pharmacology & pharmacy (3344) 3344
oncology (3134) 3134
sildenafil citrate (2867) 2867
piperazines - administration & dosage (2830) 2830
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (2301) 2301
psychiatry (1985) 1985
mice (1866) 1866
hematology (1852) 1852
rats (1771) 1771
dose-response relationship, drug (1715) 1715
imatinib (1692) 1692
antipsychotic agents - therapeutic use (1654) 1654
protein kinase inhibitors - therapeutic use (1604) 1604
adolescent (1594) 1594
purines (1472) 1472
sulfones (1465) 1465
cancer (1395) 1395
erectile dysfunction - drug therapy (1365) 1365
aripiprazole (1335) 1335
drug therapy (1327) 1327
sildenafil (1310) 1310
double-blind method (1302) 1302
neurosciences (1274) 1274
clinical trials as topic (1257) 1257
therapy (1249) 1249
care and treatment (1246) 1246
time factors (1228) 1228
pyrimidines - pharmacology (1211) 1211
chronic myelogenous leukemia (1208) 1208
phosphodiesterase inhibitors - therapeutic use (1198) 1198
sulfones - therapeutic use (1189) 1189
quinolones - therapeutic use (1156) 1156
research (1156) 1156
chronic myeloid-leukemia (1089) 1089
analysis (1074) 1074
double-blind (1068) 1068
mutation (1063) 1063
vasodilator agents - therapeutic use (1049) 1049
efficacy (1047) 1047
purines - therapeutic use (1030) 1030
antineoplastic agents - pharmacology (1020) 1020
protein-tyrosine kinases - antagonists & inhibitors (1019) 1019
drug therapy, combination (1013) 1013
aged, 80 and over (995) 995
cell line, tumor (992) 992
young adult (988) 988
thiazoles - therapeutic use (987) 987
piperazines - pharmacokinetics (968) 968
schizophrenia - drug therapy (962) 962
schizophrenia (935) 935
antipsychotic agents - adverse effects (927) 927
medicine & public health (906) 906
chronic myeloid leukemia (903) 903
leukemia, myelogenous, chronic, bcr-abl positive - genetics (896) 896
pyrimidines - adverse effects (892) 892
gastrointestinal stromal tumors - drug therapy (884) 884
pyrimidines - administration & dosage (870) 870
medicine, general & internal (865) 865
benzamides - therapeutic use (855) 855
drug resistance, neoplasm (844) 844
erectile dysfunction (823) 823
apoptosis (815) 815
clinical neurology (810) 810
expression (792) 792
health aspects (773) 773
child (768) 768
follow-up studies (760) 760
disease models, animal (759) 759
prognosis (754) 754
abridged index medicus (737) 737
cardiac & cardiovascular systems (736) 736
safety (734) 734
imidazoles - therapeutic use (722) 722
urology & nephrology (719) 719
administration, oral (705) 705
leukemia (697) 697
piperazines - chemistry (692) 692
risk factors (687) 687
antineoplastic combined chemotherapy protocols - therapeutic use (676) 676
rats, sprague-dawley (665) 665
tumors (657) 657
drug administration schedule (650) 650
fusion proteins, bcr-abl - genetics (648) 648
antineoplastic agents - adverse effects (645) 645
bcr-abl (638) 638
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18420) 18420
German (454) 454
French (446) 446
Japanese (394) 394
Chinese (241) 241
Italian (194) 194
Russian (190) 190
Spanish (152) 152
Polish (74) 74
Portuguese (61) 61
Hungarian (41) 41
Dutch (34) 34
Czech (27) 27
Danish (25) 25
Swedish (21) 21
Romanian (14) 14
Finnish (11) 11
Bulgarian (10) 10
Hebrew (10) 10
Norwegian (10) 10
Croatian (9) 9
Slovak (5) 5
Turkish (5) 5
Ukrainian (3) 3
Korean (2) 2
Serbian (2) 2
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2011, Volume 2013, Issue 1, p. CD006626
Journal Article
Head & Neck, ISSN 1043-3074, 05/2012, Volume 34, Issue 5, pp. 736 - 745
The incidence of thyroid cancer continues to increase and this neoplasia remains the most common endocrine malignancy. No effective systemic treatment... 
epidermal growth factor (EGF) | RET | immunomodulator | vascular disrupting agent | multi‐kinase inhibitor | vascular endothelial growth factor (VEGF) | thyroid cancer | histone acetylation | B‐Raf | heat shock protein (HSP) | multi-kinase inhibitor | B-Raf | SURGERY | HISTONE DEACETYLASE INHIBITOR | SUBEROYLANILIDE HYDROXAMIC ACID | ABL TYROSINE KINASE | PROTEASOME INHIBITION | CELL-CYCLE ARREST | VALPROIC ACID | DEPSIPEPTIDE FR901228 | PHASE-II TRIAL | OTORHINOLARYNGOLOGY | IMATINIB MESYLATE | ENDOTHELIAL GROWTH-FACTOR | Niacinamide - analogs & derivatives | Anilides - therapeutic use | Bibenzyls - therapeutic use | Humans | Antineoplastic Agents - therapeutic use | Benzenesulfonates - therapeutic use | Pyrazines - therapeutic use | Boronic Acids - therapeutic use | Proto-Oncogene Proteins c-kit - antagonists & inhibitors | Thalidomide - analogs & derivatives | Angiogenesis Inhibitors - therapeutic use | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Valproic Acid - therapeutic use | Depsipeptides - therapeutic use | Imidazoles - therapeutic use | Lactams, Macrocyclic - therapeutic use | Pyrroles - therapeutic use | Pyridines - therapeutic use | Bortezomib | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Piperazines - therapeutic use | Imatinib Mesylate | Sulfonamides - therapeutic use | Thyroid Neoplasms - drug therapy | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Quinazolines - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Hydroxamic Acids - therapeutic use | Indoles - therapeutic use | Histone Deacetylase Inhibitors - therapeutic use | Quinolines - therapeutic use | Benzamides | Thalidomide - therapeutic use | Benzoquinones - therapeutic use | Indazoles - therapeutic use | Protein-Tyrosine Kinases - antagonists & inhibitors
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2010, Volume 2013, Issue 5, p. CD006654
Journal Article
Circulation, ISSN 0009-7322, 07/2016, Volume 134, Issue 3, pp. 248 - 261
Vitamin K antagonists are commonly used by clinicians to provide anticoagulation to patients who have or are at risk of having thrombotic events. In addition... 
anticoagulants | atrial fibrillation | venous thromboembolism | hemorrhage | CARDIAC & CARDIOVASCULAR SYSTEMS | ACTIVATED FACTOR-VII | ATRIAL-FIBRILLATION | IN-VITRO | THROMBIN GENERATION | DABIGATRAN ETEXILATE | PROTHROMBIN COMPLEX CONCENTRATE | SYMPTOMATIC VENOUS THROMBOEMBOLISM | PRACTICAL MANAGEMENT | PERIPHERAL VASCULAR DISEASE | STAGE RENAL-DISEASE | FACTOR XA INHIBITOR | Recombinant Proteins - therapeutic use | Plasma | Dabigatran - adverse effects | Pyrazoles - therapeutic use | Humans | Hemorrhage - prevention & control | Recombinant Proteins - adverse effects | Thiazoles - therapeutic use | Factor VIIa - therapeutic use | Arginine - analogs & derivatives | Dabigatran - therapeutic use | Thiazoles - adverse effects | Pyridines - adverse effects | Rivaroxaban - adverse effects | Factor Xa - therapeutic use | Rivaroxaban - therapeutic use | Factor Xa - adverse effects | Pyrazoles - adverse effects | Pyridines - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Administration, Oral | Antithrombins - therapeutic use | Piperazines - therapeutic use | Dabigatran - antagonists & inhibitors | Piperazines - adverse effects | Factor Xa Inhibitors - therapeutic use | Hemorrhage - drug therapy | Antithrombins - adverse effects | Factor Xa Inhibitors - adverse effects | Blood Coagulation Factors - therapeutic use | Arginine - adverse effects | Pyridones - therapeutic use | Hemorrhage - chemically induced | Hemostatics - therapeutic use | Arginine - therapeutic use | Pyridones - adverse effects
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 03/2017, Volume 2017, Issue 3, p. CD006324
Background Between 40% and 70% of people with treatment‐resistant schizophrenia do not respond to clozapine, despite adequate blood levels. For these people, a... 
Drugs | Clinical care ‐ by specific additional problem | Anti‐psychotics | Mental health | Amisulpride | Schizophrenia | Haloperidol | Aripiprazole | Sulpiride | Schizophrenia & psychosis | Antipsychotic Agents | Thiazoles | Drug Therapy, Combination | Risperidone | Weight Gain | Drug Resistance | Clinical care ‐ by treatment category | Piperazines | Quetiapine Fumarate | Clozapine | Randomized Controlled Trials as Topic | Dibenzothiazepines | Treatment resistant | General | Antipsychotic medication: atypical | Medicine General & Introductory Medical Sciences | Risperidone [therapeutic use] | REFRACTORY SCHIZOPHRENIA | EFFICACY | Humans | STATISTICS NOTES | Male | RISPERIDONE | MEDICINE, GENERAL & INTERNAL | Schizophrenia [drug therapy] | Thiazoles [therapeutic use] | Female | Clozapine [adverse effects; therapeutic use] | Sulpiride [analogs & derivatives; therapeutic use] | Dibenzothiazepines [therapeutic use] | Antipsychotic Agents [adverse effects; therapeutic use] | AUGMENTATION | DrugTherapy, Combination | NETWORK METAANALYSIS | ARIPIPRAZOLE-CLOZAPINE | SUBOPTIMAL RESPONSE | DOUBLE-BLIND | RATING-SCALE | Piperazines [therapeutic use] | Clozapine - therapeutic use | Antipsychotic Agents - adverse effects | Thiazoles - therapeutic use | Aripiprazole - adverse effects | Sulpiride - analogs & derivatives | Dibenzothiazepines - therapeutic use | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Aripiprazole - therapeutic use | Adult | Sulpiride - adverse effects | Sulpiride - therapeutic use | Haloperidol - therapeutic use | Piperazines - therapeutic use | Haloperidol - adverse effects | Schizophrenia - drug therapy | Clozapine - adverse effects
Journal Article